Home > Quotes > SPPI

Spectrum Pharmaceuticals, Inc.Common Stock Quote & Summary Data

Get SPPI Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading SPPI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Spectrum Pharmaceuticals, Inc.Common Stock Intraday Chart

News for SPPI

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 7.25 $ 7.74
Low $ 7.03 $ 4.14

The current last sale of $7.09 is 71.26% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

Our primary strategy is comprised of acquiring, developing, and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. In addition to an efficient in-house clinical development organization with regulatory and data management capabilities, we have established a commercial infrastructure for our marketed products. Currently, we have six approved oncology/hematology products that target different types of non-Hodgkin's lymphoma ("NHL"), advanced metastatic colorectal cancer, acute lymphoblastic leukemia ("ALL"), and multiple myeloma ("MM"). We also have two drugs in late stage development: *SPI-2012, is being developed for chemotherapy-induced neutropenia in patients with breast cancer.  ... More ...  

Risk Grade

Where does SPPI fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?